Abdelrahman Y. Fouda

Abdelrahman Y. Fouda is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. He leads the Fouda Lab, which focuses on central nervous system (CNS) injury mechanisms, particularly in the retina and brain. His research employs molecular, cellular, and animal models to study diseases like diabetic retinopathy, traumatic optic neuropathy, and stroke. Key areas include myeloid cell modulation (macrophages/microglia) and neurovascular repair. Dr. Fouda’s lab is funded by NIH/NEI and has access to advanced retinal imaging and electrophysiology equipment.

• Education:
  • B.Pharm, Cairo University School of Pharmacy (2002-2007)
  • Ph.D., University of Georgia Clinical and Experimental Therapeutics (2011-2015)
  • Postdoctoral training at University of Georgia (2015-2016) and Augusta University (2016-2021)

Research interests emphasize immune cell interactions in CNS diseases, targeting arginase pathways and HDAC3 to promote reparative phenotypes. Recent grants include the UAMS Hornick Stroke Award (2024-2025) and NIH R00 EY029373 (2021-2024). His lab’s innovations include pegylated arginase 1 therapies and proteomic analysis for retinal injury biomarkers.

• Key Awards:
  • AHA Postdoctoral Fellowship (2018-2020)
  • NIH K99/R00 Pathway to Independence Award
• Labs/Teams: Fouda Lab Group with specialized equipment for in vivo retinal imaging (Bioptigen SDOIS) and electroretinography (Celeris ERG).

Dr. Fouda’s work bridges bench-to-bedside translational research, aiming to develop therapies for retinal and CNS injuries through precise molecular targeting.